T1	Participants 74 147	neuroendocrino-immunological effect inhibited by exogenous glucocorticoid
T2	Participants 221 308	hypothalamus-pituitary-adrenal-thymus (HPAT) axis inhibited by exogenous glucocorticoid
T3	Participants 471 482	65 patients
T5	Participants 1549 1623	neuroendocrino-immunological effect inhibited by exogenous glucocorticoid.
